Page last updated: 2024-09-04

levofloxacin and Kahler Disease

levofloxacin has been researched along with Kahler Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's8 (61.54)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Jain, A; Jandial, A; Khadwal, A; Lad, D; Malhotra, P; Prakash, G; Ray, P; Sachdeva, MUS; Singh, C; Sreedharanunni, S; Suri, V; Varma, N; Varma, S1
Belsham, E; Bowcock, S; Campbell, G; Dawkins, B; Dignum, H; Drayson, MT; Dunn, JA; Hamblin, M; Harrison, B; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Karunanithi, K; Lokare, A; Low, E; Meads, D; Monahan, I; Neilson, J; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K1
Ramasamy, K1
Bowcock, S; Dawkins, B; Drayson, MT; Dunn, JA; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Low, E; Meads, D; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K1
Harrison, SJ; Slavin, MA; Teh, BW; Thursky, KA; Worth, LJ1
Albrich, WC; Boggian, K1
Bowcock, S; Drayson, MT; Dunn, JA; Iqbal, G; Planche, T; Pratt, G; Yong, K1
Copeland, V; McLaughlin, M; Trifilio, S1
Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M1
Ahn, JS; Jang, HC; Jung, SH; Kang, SJ; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Yang, DH1
Babalola, O; Baird, P; Devoe, CE; Hoang, H; Jhaveri, KD; Leung, S; Wanchoo, R1
Gergis, U; Jacobs, SE; Mark, TM; Satlin, MJ; Shore, TB; Soave, R; Vardhana, S; Walsh, TJ1
Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H1

Trials

3 trial(s) available for levofloxacin and Kahler Disease

ArticleYear
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
    The Lancet. Oncology, 2019, Volume: 20, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Prospective Studies

2019
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Health technology assessment (Winchester, England), 2019, Volume: 23, Issue:62

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridioides difficile; Cost-Benefit Analysis; Cross Infection; England; Female; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Northern Ireland; Technology Assessment, Biomedical; Wales

2019
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40, Issue:8

    Topics: Amyloidosis; Anemia, Aplastic; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Middle Aged; Multiple Myeloma; Neutropenia; Ofloxacin

2005

Other Studies

10 other study(ies) available for levofloxacin and Kahler Disease

ArticleYear
Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25, Issue:5

    Topics: Adult; Aged; Antibiotic Prophylaxis; Female; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Transplantation, Autologous

2023
Reducing infection-related morbidity and mortality in patients with myeloma.
    The Lancet. Oncology, 2019, Volume: 20, Issue:12

    Topics: Diphosphonates; Double-Blind Method; Humans; Infections; Levofloxacin; Multiple Myeloma

2019
Levofloxacin prophylaxis in patients with myeloma.
    The Lancet. Oncology, 2020, Volume: 21, Issue:2

    Topics: Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Humans; Levofloxacin; Multiple Myeloma

2020
Levofloxacin prophylaxis in patients with myeloma.
    The Lancet. Oncology, 2020, Volume: 21, Issue:2

    Topics: Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Humans; Levofloxacin; Multiple Myeloma

2020
Levofloxacin prophylaxis in patients with myeloma - Authors' reply.
    The Lancet. Oncology, 2020, Volume: 21, Issue:2

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Humans; Levofloxacin; Multiple Myeloma

2020
Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
    Clinical transplantation, 2018, Volume: 32, Issue:1

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Retrospective Studies

2018
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies

2014
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens.
    International journal of hematology, 2014, Volume: 100, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Comorbidity; Female; Humans; Incidence; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Pyrazines; Treatment Outcome

2014
A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:2

    Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Levofloxacin; Multiple Myeloma; Thalidomide

2016
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:10

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Female; Filgrastim; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Levofloxacin; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous

2015